Beneficial metabolic effects of nateglinide versus acarbose in patients with newly-diagnosed type 2 diabetes

被引：0
作者：
Hong-wei Gao
Chao Xie
Hai-ning Wang
Yu-jing Lin
Tian-pei Hong
机构：
[1] Peking University Third Hospital,Department of Endocrinology
来源：
Acta Pharmacologica Sinica | 2007年 / 28卷
关键词：
nateglinide; acarbose; free fatty acids; asymmetric dimethylarginine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：534 / 539
页数：5
相关论文
共 50 条
  • [21] Effects of nateglinide and acarbose on glycemic excursions in standardized carbohydrate and mixed-meal tests in drug-naive type 2 diabetic patients
    Li, Hai
    Xu, Wenming
    Liu, Juan
    Chen, Ailing
    Liao, Zhihong
    Li, Yanbing
    BIOMEDICAL REPORTS, 2013, 1 (06) : 913 - 917
  • [22] Acarbose in the treatment of elderly patients with type 2 diabetes
    Josse, RG
    Chiasson, JL
    Ryan, EA
    Lau, DCW
    Ross, SA
    Yale, JF
    Leiter, LA
    Maheux, P
    Tessier, D
    Wolever, TMS
    Gerstein, H
    Rodger, NW
    Dornan, JM
    Murphy, LJ
    Rabasa-Lhoret, R
    Meneilly, GS
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2003, 59 (01) : 37 - 42
  • [23] Improved post-prandial ghrelin response by nateglinide or acarbose therapy contributes to glucose stability in Type 2 diabetic patients
    Zheng, F.
    Yin, X.
    Lu, W.
    Zhou, J.
    Yuan, H.
    Li, H.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2013, 36 (07) : 489 - 496
  • [24] Improved post-prandial ghrelin response by nateglinide or acarbose therapy contributes to glucose stability in Type 2 diabetic patients
    F. Zheng
    X. Yin
    W. Lu
    J. Zhou
    H. Yuan
    H. Li
    Journal of Endocrinological Investigation, 2013, 36 : 489 - 496
  • [25] Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report
    Miao-yan Zheng
    Ju-hong Yang
    Chun-yan Shan
    Hong-tao Zhou
    Yan-guang Xu
    Ying Wang
    Hui-zhu Ren
    Bao-cheng Chang
    Li-ming Chen
    Cardiovascular Diabetology, 12
  • [26] Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report
    Zheng, Miao-yan
    Yang, Ju-hong
    Shan, Chun-yan
    Zhou, Hong-tao
    Xu, Yan-guang
    Wang, Ying
    Ren, Hui-zhu
    Chang, Bao-cheng
    Chen, Li-ming
    CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [27] Effect of nateglinide on the size of LDL particles in patients with type 2 diabetes
    Yutaka Onishi
    Takashi Fujisawa
    Kazuhiko Sakaguchi
    Mitsuo Maeda
    Advances in Therapy, 2006, 23 : 549 - 555
  • [28] Nateglinide is useful for nonalcoholic steatohepatitis (NASH) patients with type 2 diabetes
    Morita, Y
    Ueno, T
    Sasaki, N
    Tateishi, Y
    Nagata, E
    Kage, M
    Sata, M
    HEPATO-GASTROENTEROLOGY, 2005, 52 (65) : 1338 - 1343
  • [29] Effect of nateglinide on the size of LDL particles in patients with type 2 diabetes
    Onishi, Yutaka
    Fujisawa, Takashi
    Sakaguchi, Kazuhiko
    Maeda, Mitsuo
    ADVANCES IN THERAPY, 2006, 23 (04) : 549 - 555
  • [30] Effects of changeover from voglibose to acarbose on postprandial triglycerides in type 2 diabetes mellitus patients
    Mihoko Matsumura
    Tsuyoshi Monden
    Yasushi Miyashita
    Yoshiaki Kawagoe
    Hiroaki Shimizu
    Yuki Nakatani
    Nozomi Domeki
    Kazunori Yanagi
    Shiori Ikeda
    Kikuo Kasai
    Advances in Therapy, 2009, 26 : 660 - 666
12345